aluates Reports

$ 0.0

Automative

Global Cone-rod Dystrophy Treatment Market Research Report 2026

Published Date: 2026-04-08

Report Code: QYRE-Auto-14N9232

Global Cone rod Dystrophy Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Cone-rod Dystrophy Treatment Market Research Report 2026

Code: QYRE-Auto-14N9232

Report

2026-04-08

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

JCyte

Nanoscope Therapeutics

SparingVision

MeiraGTx Limited

AGTC

Biogen

Second Sight Medical

GlaxoSmithKline PLC

Johnson and Johnson

Sanofi

Pfizer Inc

Novartis

Abbott Laboratories

Cone-rod Dystrophy Treatment Market Size

The global Cone-rod Dystrophy Treatment market was valued at US$ 73 million in 2025 and is anticipated to reach US$ 334 million by 2032, at a CAGR of 24.6% from 2026 to 2032.

Cone-rod Dystrophy Treatment Market

Cone dystrophy is an eye disease involving the cones, which are specialized structures in the eye used for color vision. Multiple forms of cone dystrophy have been discovered, and the condition is hereditary in nature. Treatment options focus on helping patients compensate for their vision loss.

The cone-rod dystrophy treatment market is driven by the increasing awareness of genetic retinal diseases and the rising number of patients diagnosed with cone-rod dystrophy (CRD). As CRD leads to progressive vision loss, especially in the central visual field, the demand for effective therapies to slow down or halt the progression of the disease is growing. Advances in genetic research and clinical trials focusing on gene therapies, retinal implants, and other innovative treatments are expected to offer promising solutions for CRD patients. Additionally, the increasing investment in ophthalmology research, as well as improved diagnostic techniques, are contributing to the market’s growth by enabling earlier diagnosis and intervention. As awareness of retinal degenerative diseases rises globally, the focus on providing better treatment options for rare eye conditions like CRD has intensified, attracting investment from both pharmaceutical companies and research institutions.

However, the market faces significant challenges, primarily due to the rarity of cone-rod dystrophy, which limits the overall patient population and slows down the development and commercialization of targeted treatments. The high costs associated with advanced therapies, particularly gene therapy and retinal prosthetics, may also restrict access for patients, especially in lower-income regions. Furthermore, despite the promising progress in treatment options, CRD is a complex disease with various genetic mutations, making the development of a universal treatment difficult. Regulatory approval processes for gene therapies and retinal treatments are long and complicated, adding to the timeline and cost of bringing new treatments to market. Additionally, there remains a need for more extensive clinical data to establish the long-term efficacy and safety of emerging therapies, which could further delay adoption.

Global Cone-rod Dystrophy Treatment includes JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, etc. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific.

This report delivers a comprehensive overview of the global Cone-rod Dystrophy Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cone-rod Dystrophy Treatment. The Cone-rod Dystrophy Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cone-rod Dystrophy Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cone-rod Dystrophy Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Cone-rod Dystrophy Treatment Market Report

Report Metric	Details
Report Name	Cone-rod Dystrophy Treatment Market
Accounted market size in 2025	US$ 73 million
Forecasted market size in 2032	US$ 334 million
CAGR	24.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Gene Therapy Stem Cell Therapy Retinal Implant Surgery
Segment by Application	Hospital Ophthalmology Department Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, Second Sight Medical, GlaxoSmithKline, Johnson And Johnson, Sanofi, Pfizer, Novartis, Abbott Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cone-rod Dystrophy Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Cone-rod Dystrophy Treatment Market growing?

Ans: The Cone-rod Dystrophy Treatment Market witnessing a CAGR of 24.6% during the forecast period 2026-2032.

What is the Cone-rod Dystrophy Treatment Market size in 2032?

Ans: The Cone-rod Dystrophy Treatment Market size in 2032 will be US$ 334 million.

Who are the main players in the Cone-rod Dystrophy Treatment Market report?

Ans: The main players in the Cone-rod Dystrophy Treatment Market are JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, Second Sight Medical, GlaxoSmithKline, Johnson And Johnson, Sanofi, Pfizer, Novartis, Abbott Laboratories

What are the Application segmentation covered in the Cone-rod Dystrophy Treatment Market report?

Ans: The Applications covered in the Cone-rod Dystrophy Treatment Market report are Hospital, Ophthalmology Department, Other

What are the Type segmentation covered in the Cone-rod Dystrophy Treatment Market report?

Ans: The Types covered in the Cone-rod Dystrophy Treatment Market report are Gene Therapy, Stem Cell Therapy, Retinal Implant Surgery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Gene Therapy

1.2.3 Stem Cell Therapy

1.2.4 Retinal Implant Surgery

1.3 Market by Application

1.3.1 Global Cone-rod Dystrophy Treatment Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Ophthalmology Department

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cone-rod Dystrophy Treatment Market Perspective (2021–2032)

2.2 Global Cone-rod Dystrophy Treatment Growth Trends by Region

2.2.1 Global Cone-rod Dystrophy Treatment Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Cone-rod Dystrophy Treatment Historic Market Size by Region (2021–2026)

2.2.3 Cone-rod Dystrophy Treatment Forecasted Market Size by Region (2027–2032)

2.3 Cone-rod Dystrophy Treatment Market Dynamics

2.3.1 Cone-rod Dystrophy Treatment Industry Trends

2.3.2 Cone-rod Dystrophy Treatment Market Drivers

2.3.3 Cone-rod Dystrophy Treatment Market Challenges

2.3.4 Cone-rod Dystrophy Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cone-rod Dystrophy Treatment Players by Revenue

3.1.1 Global Top Cone-rod Dystrophy Treatment Players by Revenue (2021–2026)

3.1.2 Global Cone-rod Dystrophy Treatment Revenue Market Share by Players (2021–2026)

3.2 Global Top Cone-rod Dystrophy Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Cone-rod Dystrophy Treatment Revenue

3.4 Global Cone-rod Dystrophy Treatment Market Concentration Ratio

3.4.1 Global Cone-rod Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cone-rod Dystrophy Treatment Revenue in 2025

3.5 Global Key Players of Cone-rod Dystrophy Treatment Head Offices and Areas Served

3.6 Global Key Players of Cone-rod Dystrophy Treatment, Products and Applications

3.7 Global Key Players of Cone-rod Dystrophy Treatment, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Cone-rod Dystrophy Treatment Breakdown Data by Type

4.1 Global Cone-rod Dystrophy Treatment Historic Market Size by Type (2021–2026)

4.2 Global Cone-rod Dystrophy Treatment Forecasted Market Size by Type (2027–2032)

5 Cone-rod Dystrophy Treatment Breakdown Data by Application

5.1 Global Cone-rod Dystrophy Treatment Historic Market Size by Application (2021–2026)

5.2 Global Cone-rod Dystrophy Treatment Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Cone-rod Dystrophy Treatment Market Size (2021–2032)

6.2 North America Cone-rod Dystrophy Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Cone-rod Dystrophy Treatment Market Size by Country (2021–2026)

6.4 North America Cone-rod Dystrophy Treatment Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cone-rod Dystrophy Treatment Market Size (2021–2032)

7.2 Europe Cone-rod Dystrophy Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Cone-rod Dystrophy Treatment Market Size by Country (2021–2026)

7.4 Europe Cone-rod Dystrophy Treatment Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Cone-rod Dystrophy Treatment Market Size (2021–2032)

8.2 Asia-Pacific Cone-rod Dystrophy Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Cone-rod Dystrophy Treatment Market Size by Region (2021–2026)

8.4 Asia-Pacific Cone-rod Dystrophy Treatment Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Cone-rod Dystrophy Treatment Market Size (2021–2032)

9.2 Latin America Cone-rod Dystrophy Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Cone-rod Dystrophy Treatment Market Size by Country (2021–2026)

9.4 Latin America Cone-rod Dystrophy Treatment Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cone-rod Dystrophy Treatment Market Size (2021–2032)

10.2 Middle East & Africa Cone-rod Dystrophy Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2021–2026)

10.4 Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 JCyte

11.1.1 JCyte Company Details

11.1.2 JCyte Business Overview

11.1.3 JCyte Cone-rod Dystrophy Treatment Introduction

11.1.4 JCyte Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.1.5 JCyte Recent Development

11.2 Nanoscope Therapeutics

11.2.1 Nanoscope Therapeutics Company Details

11.2.2 Nanoscope Therapeutics Business Overview

11.2.3 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Introduction

11.2.4 Nanoscope Therapeutics Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.2.5 Nanoscope Therapeutics Recent Development

11.3 SparingVision

11.3.1 SparingVision Company Details

11.3.2 SparingVision Business Overview

11.3.3 SparingVision Cone-rod Dystrophy Treatment Introduction

11.3.4 SparingVision Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.3.5 SparingVision Recent Development

11.4 MeiraGTx

11.4.1 MeiraGTx Company Details

11.4.2 MeiraGTx Business Overview

11.4.3 MeiraGTx Cone-rod Dystrophy Treatment Introduction

11.4.4 MeiraGTx Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.4.5 MeiraGTx Recent Development

11.5 AGTC

11.5.1 AGTC Company Details

11.5.2 AGTC Business Overview

11.5.3 AGTC Cone-rod Dystrophy Treatment Introduction

11.5.4 AGTC Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.5.5 AGTC Recent Development

11.6 Biogen

11.6.1 Biogen Company Details

11.6.2 Biogen Business Overview

11.6.3 Biogen Cone-rod Dystrophy Treatment Introduction

11.6.4 Biogen Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.6.5 Biogen Recent Development

11.7 Second Sight Medical

11.7.1 Second Sight Medical Company Details

11.7.2 Second Sight Medical Business Overview

11.7.3 Second Sight Medical Cone-rod Dystrophy Treatment Introduction

11.7.4 Second Sight Medical Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.7.5 Second Sight Medical Recent Development

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Details

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Cone-rod Dystrophy Treatment Introduction

11.8.4 GlaxoSmithKline Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.8.5 GlaxoSmithKline Recent Development

11.9 Johnson And Johnson

11.9.1 Johnson And Johnson Company Details

11.9.2 Johnson And Johnson Business Overview

11.9.3 Johnson And Johnson Cone-rod Dystrophy Treatment Introduction

11.9.4 Johnson And Johnson Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.9.5 Johnson And Johnson Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Cone-rod Dystrophy Treatment Introduction

11.10.4 Sanofi Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.10.5 Sanofi Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Details

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Cone-rod Dystrophy Treatment Introduction

11.11.4 Pfizer Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.11.5 Pfizer Recent Development

11.12 Novartis

11.12.1 Novartis Company Details

11.12.2 Novartis Business Overview

11.12.3 Novartis Cone-rod Dystrophy Treatment Introduction

11.12.4 Novartis Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.12.5 Novartis Recent Development

11.13 Abbott Laboratories

11.13.1 Abbott Laboratories Company Details

11.13.2 Abbott Laboratories Business Overview

11.13.3 Abbott Laboratories Cone-rod Dystrophy Treatment Introduction

11.13.4 Abbott Laboratories Revenue in Cone-rod Dystrophy Treatment Business (2021–2026)

11.13.5 Abbott Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

JCyte

Nanoscope Therapeutics

SparingVision

MeiraGTx Limited

AGTC

Biogen

Second Sight Medical

GlaxoSmithKline PLC

Johnson and Johnson

Sanofi

Pfizer Inc

Novartis

Abbott Laboratories

List of Tables

Table 1. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Gene Therapy

Table 3. Key Players of Stem Cell Therapy

Table 4. Key Players of Retinal Implant Surgery

Table 5. Global Cone-rod Dystrophy Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Cone-rod Dystrophy Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Cone-rod Dystrophy Treatment Market Size by Region (US$ Million), 2021–2026

Table 8. Global Cone-rod Dystrophy Treatment Market Share by Region (2021–2026)

Table 9. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Cone-rod Dystrophy Treatment Market Share by Region (2027–2032)

Table 11. Cone-rod Dystrophy Treatment Market Trends

Table 12. Cone-rod Dystrophy Treatment Market Drivers

Table 13. Cone-rod Dystrophy Treatment Market Challenges

Table 14. Cone-rod Dystrophy Treatment Market Restraints

Table 15. Global Cone-rod Dystrophy Treatment Revenue by Players (US$ Million), 2021–2026

Table 16. Global Cone-rod Dystrophy Treatment Market Share by Players (2021–2026)

Table 17. Global Top Cone-rod Dystrophy Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cone-rod Dystrophy Treatment Revenue, 2025

Table 18. Ranking of Global Top Cone-rod Dystrophy Treatment Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Cone-rod Dystrophy Treatment Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Cone-rod Dystrophy Treatment, Headquarters and Area Served

Table 21. Global Key Players of Cone-rod Dystrophy Treatment, Products and Applications

Table 22. Global Key Players of Cone-rod Dystrophy Treatment, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Cone-rod Dystrophy Treatment Market Size by Type (US$ Million), 2021–2026

Table 25. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2021–2026)

Table 26. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2027–2032)

Table 28. Global Cone-rod Dystrophy Treatment Market Size by Application (US$ Million), 2021–2026

Table 29. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2021–2026)

Table 30. Global Cone-rod Dystrophy Treatment Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2027–2032)

Table 32. North America Cone-rod Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2021–2026

Table 34. North America Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Cone-rod Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Cone-rod Dystrophy Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Cone-rod Dystrophy Treatment Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Cone-rod Dystrophy Treatment Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Cone-rod Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Cone-rod Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (US$ Million), 2027–2032

Table 47. JCyte Company Details

Table 48. JCyte Business Overview

Table 49. JCyte Cone-rod Dystrophy Treatment Product

Table 50. JCyte Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 51. JCyte Recent Development

Table 52. Nanoscope Therapeutics Company Details

Table 53. Nanoscope Therapeutics Business Overview

Table 54. Nanoscope Therapeutics Cone-rod Dystrophy Treatment Product

Table 55. Nanoscope Therapeutics Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 56. Nanoscope Therapeutics Recent Development

Table 57. SparingVision Company Details

Table 58. SparingVision Business Overview

Table 59. SparingVision Cone-rod Dystrophy Treatment Product

Table 60. SparingVision Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 61. SparingVision Recent Development

Table 62. MeiraGTx Company Details

Table 63. MeiraGTx Business Overview

Table 64. MeiraGTx Cone-rod Dystrophy Treatment Product

Table 65. MeiraGTx Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 66. MeiraGTx Recent Development

Table 67. AGTC Company Details

Table 68. AGTC Business Overview

Table 69. AGTC Cone-rod Dystrophy Treatment Product

Table 70. AGTC Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 71. AGTC Recent Development

Table 72. Biogen Company Details

Table 73. Biogen Business Overview

Table 74. Biogen Cone-rod Dystrophy Treatment Product

Table 75. Biogen Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 76. Biogen Recent Development

Table 77. Second Sight Medical Company Details

Table 78. Second Sight Medical Business Overview

Table 79. Second Sight Medical Cone-rod Dystrophy Treatment Product

Table 80. Second Sight Medical Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 81. Second Sight Medical Recent Development

Table 82. GlaxoSmithKline Company Details

Table 83. GlaxoSmithKline Business Overview

Table 84. GlaxoSmithKline Cone-rod Dystrophy Treatment Product

Table 85. GlaxoSmithKline Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 86. GlaxoSmithKline Recent Development

Table 87. Johnson And Johnson Company Details

Table 88. Johnson And Johnson Business Overview

Table 89. Johnson And Johnson Cone-rod Dystrophy Treatment Product

Table 90. Johnson And Johnson Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 91. Johnson And Johnson Recent Development

Table 92. Sanofi Company Details

Table 93. Sanofi Business Overview

Table 94. Sanofi Cone-rod Dystrophy Treatment Product

Table 95. Sanofi Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 96. Sanofi Recent Development

Table 97. Pfizer Company Details

Table 98. Pfizer Business Overview

Table 99. Pfizer Cone-rod Dystrophy Treatment Product

Table 100. Pfizer Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 101. Pfizer Recent Development

Table 102. Novartis Company Details

Table 103. Novartis Business Overview

Table 104. Novartis Cone-rod Dystrophy Treatment Product

Table 105. Novartis Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 106. Novartis Recent Development

Table 107. Abbott Laboratories Company Details

Table 108. Abbott Laboratories Business Overview

Table 109. Abbott Laboratories Cone-rod Dystrophy Treatment Product

Table 110. Abbott Laboratories Revenue in Cone-rod Dystrophy Treatment Business (US$ Million), 2021–2026

Table 111. Abbott Laboratories Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Cone-rod Dystrophy Treatment Picture

Figure 2. Global Cone-rod Dystrophy Treatment Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Cone-rod Dystrophy Treatment Market Share by Type: 2025 vs 2032

Figure 4. Gene Therapy Features

Figure 5. Stem Cell Therapy Features

Figure 6. Retinal Implant Surgery Features

Figure 7. Global Cone-rod Dystrophy Treatment Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Cone-rod Dystrophy Treatment Market Share by Application: 2025 vs 2032

Figure 9. Hospital Case Studies

Figure 10. Ophthalmology Department Case Studies

Figure 11. Other Case Studies

Figure 12. Cone-rod Dystrophy Treatment Report Years Considered

Figure 13. Global Cone-rod Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Cone-rod Dystrophy Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Cone-rod Dystrophy Treatment Market Share by Region: 2025 vs 2032

Figure 16. Global Cone-rod Dystrophy Treatment Market Share by Players in 2025

Figure 17. Global Cone-rod Dystrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Cone-rod Dystrophy Treatment Revenue in 2025

Figure 19. North America Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Cone-rod Dystrophy Treatment Market Share by Country (2021–2032)

Figure 21. United States Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Cone-rod Dystrophy Treatment Market Share by Country (2021–2032)

Figure 25. Germany Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Cone-rod Dystrophy Treatment Market Share by Region (2021–2032)

Figure 33. China Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Cone-rod Dystrophy Treatment Market Share by Country (2021–2032)

Figure 41. Mexico Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Country (2021–2032)

Figure 45. Israel Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Cone-rod Dystrophy Treatment Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. JCyte Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 49. Nanoscope Therapeutics Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 50. SparingVision Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 51. MeiraGTx Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 52. AGTC Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 53. Biogen Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 54. Second Sight Medical Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 55. GlaxoSmithKline Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 56. Johnson And Johnson Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 57. Sanofi Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 58. Pfizer Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 59. Novartis Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 60. Abbott Laboratories Revenue Growth Rate in Cone-rod Dystrophy Treatment Business (2021–2026)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Choroideremia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinitis Pigmentosa Retinitis Market Insights Forecast to 2030

Global Retinal Disorders Treatment Market Research Report 2024

Global Spinal Muscular Atrophy SMA Treatment Market Research Report 2024

Global Inherited Retinal Disease Treatment Market Research Report 2024

Global Macular Degeneration Treatment Market Research Report 2024

Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024

Geographic Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eye Disorders Treatments Market Research Report 2024

Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Myotonic Dystrophy Treatment Market Research Report 2025

Global Open Angle Glaucoma Therapeutics Market Insights Forecast to 2030

Optic Neuropathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Macular Edema and Macular Degeneration Market Research Report 2025

Global Glaucoma Treatment Devices Market Research Report 2024

Spinal Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions